St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Research
Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
A hypothesis can’t be right unless it can be proven wrong
Always being right is wrong — Learn how science can be corrupted by poor experiments and theories that cannot be disproven.
Exploring the Sonic Hedgehog pathway – how embryonic cells broadcast their growth instructions
New research of the Sonic Hedgehog pathway shows potential targets for cancer treatments. Read how this cellular pathway plays a critical role in normal and cancerous development.
Genetic testing in childhood cancer: a Pediatric Cancer Genome Project update
Germline mutations can contribute to leukemia, retinoblastoma, and other pediatric cancers. Learn about advancements in the first landmark effort specifically designed to better understand these mutations and develop novel treatment methods.
There are thousands of whole genome sequences in St. Jude Cloud. And you can use them.
Because of St. Jude Cloud, terabytes of pediatric cancer genomic data can now be readily accessed, analyzed and visualized.
Safety in numbers: Advanced biostatistical model resolves questions on vancomycin side effects
Dr. Josh Wolf explains how biostatistics resolved safety questions on preemptive vancomycin for acute myeloid leukemia patients after chemotherapy.
A vaccine to prevent cancer? It’s already here.
Many adolescents fail to get a key vaccination that can prevent cancer. Learn what doctors know about the HPV cancer vaccine.
Five ways to take confirmation bias out of your experimental results
The most important part of research is that you must not fool yourself — and you’re the easiest person to fool.
Blood's oxygen transporter revealed as power source for aggressive pediatric cancer
Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.
ASH 2017: Preliminary results show gene therapy gains in SCID
Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.
ASH 2017: GATA3 in Ph-like acute lymphoblastic leukemia
Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.